the Prevention
& treatment of
Infections
Our mission is to improve established protocols for control and preventive measures against infectious diseases and subsequent infections that are both costly and increase risk of complications to patients.
PRE-CLINICAL AND THIRD PARTY
Our product chemistries are at various commercial, licensing and regulatory stages. We use scientific rigor in testing of our product safety and efficacy. These studies are performed per Good Laboratory Practices (GLP) or in compliance with applicable USP, EN and ISO standards.
Our proprietary antimicrobial platforms are highly effective against gram-positive and gram-negative bacteria including antibiotic resistant strains, viruses, fungi, mold and spores both on hard surfaces and on wounds without encouraging the emergence of additional resistant pathogens.
Product uniquely designed to improve the spread of infectious diseases.according to Center for Disease Control (CDC) “HAIs are infections resulting from complications of healthcare. They are linked with high morbidity and mortality. On any given day, 1 in 31 hospital patients has an HAI (an infection while being treated in a medical facility). Additional infections occur in other healthcare settings. Many HAIs are caused by the most serious antibiotic-resistant bacteria and can lead to sepsis or death.”
“HAIs in U.S. hospitals have direct medical costs of at least $28.4 billion each year. They also account for an additional $12.4 billion in costsexternal icon to society from early deaths and lost productivity.”
“Our mission at Spectrum Antimicrobials is to improve patient lives with innovative anti-infective solutions. Our team utilizes their scientific expertise and talent to passionately develop first-in-class products.”